Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1271935 | 0.78 | CES2 (0.33) | GPR84FFAR1 | |
| SCHEMBL909346 | 0.74 | CA1 (0.36) | GPR84FFAR1CA1 | |
| SCHEMBL3295870 | 0.73 | CES2 (0.38) | GPR84FFAR1 | |
| SCHEMBL98889 | 0.72 | CES2 (0.34) | GPR84FFAR1CA1MAPT | |
| SCHEMBL6756058 | 0.72 | CES2 (0.34) | GPR84FFAR1CA1MAPT | |
| SCHEMBL98645 | 0.68 | GPR84 (0.33) | GPR84FFAR1CA1 | |
| SCHEMBL4953548 | 0.68 | GPR84 (0.41) | GPR84FFAR1MAPT | |
| SCHEMBL1437090 | 0.67 | BBOX1 (0.30) | — | |
| SCHEMBL11089321 | 0.67 | CES2 (0.31) | — | |
| SCHEMBL9197775 | 0.66 | BBOX1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100136079-A1 | Antiseptic wipes | KELLY ALBERT R | 2010-06-03 | — | — | US | claimed |
| EP-4017597-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2022-06-29 | — | — | EP | disclosed |
| EP-4017596-A1 | PERSONAL CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021183462-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2021-09-16 | — | — | WO | disclosed |
| WO-2021183464-A1 | PERSONAL CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2021-09-16 | — | — | WO | disclosed |
| WO-2021077133-A1 | BIODEGRADABLE AND/OR HOME COMPOSTABLE SACHET CONTAINING A SOLID ARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2021-04-22 | — | — | WO | disclosed |
| US-8357392-B2 | Dry antiseptic wipes comprising an amphoteric surfactant | KELLY ALBERT R (US) | 2013-01-22 | — | — | US | disclosed |
| US-20120055510-A1 | Antiseptic Wipes | KELLY ALBERT R (US) | 2012-03-08 | — | — | US | disclosed |
| EP-2382231-A2 | NEW COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | Sederma (FR) | 2011-11-02 | — | — | EP | disclosed |
| EP-2382230-A2 | KXK-PEPTIDE COMPOSITIONS FOR COSMETIC AND DERMO-PHARMACEUTIC USES | Sederma (FR) | 2011-11-02 | — | — | EP | disclosed |
| EP-2170252-A2 | METHOD OF STABILIZING A POLYSILOXANE EMULSION AND COMPOSITIONS CONTAINING STABILIZED EMULSIONS | Nalco Company (US) | 2010-04-07 | — | — | EP | disclosed |
| WO-2009036160-A1 | COMPOSITION COMPRISING ONE MORE HYDROPHOBICALLY MODIFIED POLYACRYLAMIDES AND METHOD OF USING SAID COMPOSITION | NALCO COMPANY (US) | 2009-03-19 | — | — | WO | disclosed |
| WO-2009018257-A2 | METHOD OF STABILIZING A POLYSILOXANE EMULSION AND COMPOSITIONS CONTAINING STABILIZED EMULSIONS | NALCO COMPANY (US) | 2009-02-05 | — | — | WO | disclosed |
| WO-2009006642-A1 | METHOD AND FORMULATION FOR COSMETIC COMPOSITIONS | SANTO DORON (US) | 2009-01-08 | — | — | WO | disclosed |
| WO-2000006100-A1 | HAIR CARE PRODUCT PROVIDING SHINE | THE PROCTER & GAMBLE COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0883399-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-16 | — | — | EP | disclosed |
| WO-1997030688-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-28 | — | — | WO | disclosed |
| EP-0305611-B1 | FOAMING ACID-CONTAINING FLUIDS | UNION OIL COMPANY OF CALIFORNIA (US) | 1991-04-24 | — | — | EP | disclosed |
| EP-0305611-A1 | Foaming acid-containing fluids | UNION OIL COMPANY OF CALIFORNIA (US) | 1989-03-08 | — | — | EP | disclosed |
| US-4737296-A | MIXTURE OF QUATERNARY AMINE AND AMPHOTERIC SURFACTANT AS FOAMING AGENT | UNION OIL COMPANY OF CALIFORNIA (US) | 1988-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120055510-A1 | Antiseptic Wipes | PRKDC, KRT18, TK1 | GPR84 2703/4885FFAR1 3511/4885CA1 2617/4885 |
| US-20100136079-A1 | Antiseptic wipes | POLR1C, CUTA, PRKDC | GPR84 1914/4885FFAR1 1838/4885CA1 3539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.